Global Glycomacropeptide GMP Supplements Market Top Leading Players with Strategies and Forecast 2022-2028

The global glycomacropeptide GMP supplements market is anticipated to grow at a significant CAGR 5% during the forecast period (2022-2028). Glycomacropeptide is created during the cheese-making process. Glycomacropeptide, unlike many other proteins, has only trace amounts of the amino acid phenylalanine. As glycomacropeptide has a low phenylalanine content, it may be a superior protein source for patients with phenylketonuria. Gout flares can be reduced by ingesting skim milk powder enriched with glycomacropeptide and a particular milk fat extract. It may also help to relieve discomfort during a gout flare-up. It is additionally used obese people to lose weight. The rising prevalence of the bipolar disorder, cavities in the teeth, diabetes, gout, heart disease, and liver disease, among others, are thus boosting the demand for glycomacropeptide GMP supplements.

The market players are also contributing significantly in the growth of the market by the adoption of various strategies including mergers and acquisitions, geographical expansion, partnerships, collaborations, and new product launches, in order to stay competitive in the market. For instance-

• In June 2017, PKU Sphere, a powdered, low-phenylalanine medical food, is launched by Vitaflo USA for the dietary control of Phenylketonuria (PKU). Vitaflo’s first glycomacropeptide GMP-based medical food, PKU Sphere, contains a balanced combination of GMP and amino acids. PKU is an inherited genetic illness that causes a reduction in the capacity to metabolize phenylalanine, an amino acid received from the diet. It affects about 1 in every 15,000 people in the US. If left untreated, a buildup of phenylalanine can lead to intellectual impairment and other major health concerns. GMP, a milk protein that is naturally low in phenylalanine, can assist PKU patients to satisfy their protein and nutrition requirements.
• In April 2017, A national prize for protein innovation has been given to Agropur USA. They created a high-purity glycomacropeptide, or GMP, which is a type of casein protein produced during the cheesemaking process. The GMP developed by Agropur can be utilized in phenylketonuria-friendly goods.

Market Coverage

• The market number available for – 2021-2028
• Base year- 2021
• Forecast period- 2022-2028
• Segment Covered-
  • By Type
  • By Distribution Channel
• Regions Covered-
  • North America
  • Europe
  • Asia-Pacific
  • Rest of the World

Competitive Landscape- Agropur Cooperative, MET-Rx Nutrition Inc., Benfatto Nutrition, Arla Foods, and Nestlé Health Science,  among others.

Key questions addressed by the report

• What is the market growth rate?
• Which segment and region dominate the market in the base year?
• Which segment and region will project the fastest growth in the market?
• How has COVID-19 impacted the market?
  • Deviation from the pre-COVID-19 forecast
  • Most affected region and segment
• Who is the leader in the market?
• How players are addressing challenges to sustain growth?
• Where is the investment opportunity?

Global Glycomacropeptide GMP Supplements Market Report by Segment

By End-Users

• Adults
• Children

By Distribution Channel

• Hypermarket/Supermarket
• Medical Stores
• Specialty Stores
• Online Stores
• Others